Birgit Bossenmaier
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Metabolism, Diabetes, and Cancer 10
- Protein Kinase Regulation and GTPase Signaling 9
- Glycosylation and Glycoproteins Research 5
- Ubiquitin and proteasome pathways 3
-
- Monoclonal and Polyclonal Antibodies Research 16
- Co-authors
- Thomas Friess (10 shared papers)Max Hasmann (2 shared papers)Helmut Burtscher (3 shared papers)Josef Endl (1 shared paper)Werner Scheuer (1 shared paper)A. Ullrich (4 shared papers)Monika Kellerer (9 shared papers)Gerhard Niederfellner (10 shared papers)
- Journals
- Cancer Research (8 papers)PLoS ONE (4 papers)Diabetologia (3 papers)Diabetes (3 papers)European Journal of Biochemistry (3 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Birgit Bossenmaier
41 papers receiving 1.7k citations
Birgit Bossenmaier's Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 757
- Radiology, Nuclear Medicine and Imaging 552
- Immunology 257
- Molecular Biology 737
- Endocrinology, Diabetes and Metabolism 160
Countries citing papers authored by Birgit Bossenmaier
This map shows the geographic impact of Birgit Bossenmaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Bossenmaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Bossenmaier more than expected).
Fields of papers citing papers by Birgit Bossenmaier
This network shows the impact of papers produced by Birgit Bossenmaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Bossenmaier. The network helps show where Birgit Bossenmaier may publish in the future.
Co-authors
The 25 scholars most cited alongside Birgit Bossenmaier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models Hit paper breakdown → | 2009 | 466 |
| 2 | 1996 | 182 | |
| 3 | 1993 | 136 | |
| 4 | 2019 | 120 | |
| 5 | 2012 | 98 | |
| 6 | 2013 | 86 | |
| 7 | 1997 | 83 | |
| 8 | 1998 | 81 | |
| 9 | 1995 | 68 | |
| 10 | 2016 | 49 | |
| 11 | 2000 | 47 | |
| 12 | 2014 | 46 | |
| 13 | 2017 | 39 | |
| 14 | 2017 | 39 | |
| 15 | 2012 | 28 | |
| 16 | 2013 | 26 | |
| 17 | 1997 | 23 | |
| 18 | 2005 | 19 | |
| 19 | 1996 | 18 | |
| 20 | Modulation of p145c-kit function in cells of patients with acute myeloblastic leukemia. | 1993 | 16 |
About Birgit Bossenmaier
Birgit Bossenmaier is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Surgery and Immunology, having authored 42 papers that have together received 1.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (16 papers), HER2/EGFR in Cancer Research (12 papers), Metabolism, Diabetes, and Cancer (10 papers), Protein Kinase Regulation and GTPase Signaling (9 papers), Pancreatic function and diabetes (8 papers), Glycosylation and Glycoproteins Research (5 papers), Cell Adhesion Molecules Research (4 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Oncology (757 citations), Radiology, Nuclear Medicine and Imaging (552 citations), Immunology (257 citations), Molecular Biology (737 citations) and Endocrinology, Diabetes and Metabolism (160 citations). Birgit Bossenmaier has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Thomas Friess, Max Hasmann, Helmut Burtscher, Josef Endl, Werner Scheuer, A. Ullrich, Monika Kellerer, Gerhard Niederfellner, Gwendlyn Kollmorgen and Denis M. Collins. Their work appears in journals such as Cancer Research, PLoS ONE, Diabetologia, Diabetes and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.